X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Panacea Biotech with Torrent Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PANACEA BIOTECH vs TORRENT PHARMA - Comparison Results

PANACEA BIOTECH    Change

Panacea Biotec is the second largest vaccine producer in India and has been ranked as the third largest biotechnology company in India (as per ABLE Survey 2006). While vaccines account for two-thirds of the company's overall revenues, the balance com... More

TORRENT PHARMA 
   Change

Torrent Pharmaceuticals Ltd. is the flagship company of the Torrent Group set up in 1959. Based in Ahmedabad, it was promoted by Mr U.N. Mehta initially as Trinity Laboratories Ltd. and was later renamed to its current name. The company derives its r... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PANACEA BIOTECH TORRENT PHARMA PANACEA BIOTECH/
TORRENT PHARMA
 
P/E (TTM) x 80.6 24.6 327.8% View Chart
P/BV x 1.8 6.0 29.7% View Chart
Dividend Yield % 0.0 3.3 -  

Financials

 PANACEA BIOTECH   TORRENT PHARMA
EQUITY SHARE DATA
    PANACEA BIOTECH
Mar-14
TORRENT PHARMA
Mar-16
PANACEA BIOTECH/
TORRENT PHARMA
5-Yr Chart
Click to enlarge
High Rs1491,720 8.6%   
Low Rs821,134 7.3%   
Sales per share (Unadj.) Rs84.1394.5 21.3%  
Earnings per share (Unadj.) Rs-18.3101.8 -18.0%  
Cash flow per share (Unadj.) Rs-6.7116.3 -5.8%  
Dividends per share (Unadj.) Rs040.00 0.0%  
Dividend yield (eoy) %02.8 0.0%  
Book value per share (Unadj.) Rs83.7200.3 41.8%  
Shares outstanding (eoy) m61.25169.22 36.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.43.6 38.0%   
Avg P/E ratio x-6.314.0 -45.0%  
P/CF ratio (eoy) x-17.212.3 -140.6%  
Price / Book Value ratio x1.47.1 19.4%  
Dividend payout %039.3 0.0%   
Avg Mkt Cap Rs m7,074241,435 2.9%   
No. of employees `0002.810.9 25.2%   
Total wages/salary Rs m1,4498,559 16.9%   
Avg. sales/employee Rs Th1,874.16,129.6 30.6%   
Avg. wages/employee Rs Th527.0785.8 67.1%   
Avg. net profit/employee Rs Th-407.71,581.3 -25.8%   
INCOME DATA
Net Sales Rs m5,15466,764 7.7%  
Other income Rs m1002,156 4.6%   
Total revenues Rs m5,25468,920 7.6%   
Gross profit Rs m-76627,204 -2.8%  
Depreciation Rs m7112,461 28.9%   
Interest Rs m1,5031,859 80.9%   
Profit before tax Rs m-2,88125,041 -11.5%   
Minority Interest Rs m110 -3,600.0%   
Prior Period Items Rs m-60-   
Extraordinary Inc (Exp) Rs m1,771-1,403 -126.2%   
Tax Rs m176,414 0.3%   
Profit after tax Rs m-1,12117,224 -6.5%  
Gross profit margin %-14.940.7 -36.5%  
Effective tax rate %-0.625.6 -2.3%   
Net profit margin %-21.825.8 -84.3%  
BALANCE SHEET DATA
Current assets Rs m3,81046,622 8.2%   
Current liabilities Rs m8,36532,843 25.5%   
Net working cap to sales %-88.420.6 -428.3%  
Current ratio x0.51.4 32.1%  
Inventory Days Days15674 209.7%  
Debtors Days Days6779 85.1%  
Net fixed assets Rs m14,48039,029 37.1%   
Share capital Rs m61846 7.2%   
"Free" reserves Rs m90331,400 2.9%   
Net worth Rs m5,12733,890 15.1%   
Long term debt Rs m5,83218,637 31.3%   
Total assets Rs m19,43390,136 21.6%  
Interest coverage x-0.914.5 -6.3%   
Debt to equity ratio x1.10.5 206.8%  
Sales to assets ratio x0.30.7 35.8%   
Return on assets %2.021.2 9.3%  
Return on equity %-21.950.8 -43.0%  
Return on capital %3.648.5 7.5%  
Exports to sales %24.543.3 56.6%   
Imports to sales %10.26.9 148.3%   
Exports (fob) Rs m1,26428,934 4.4%   
Imports (cif) Rs m5254,584 11.4%   
Fx inflow Rs m1,53929,185 5.3%   
Fx outflow Rs m9426,021 15.6%   
Net fx Rs m59723,165 2.6%   
CASH FLOW
From Operations Rs m59927,132 2.2%  
From Investments Rs m-438-7,014 6.2%  
From Financial Activity Rs m-303-14,352 2.1%  
Net Cashflow Rs m-1415,767 -2.5%  

Share Holding

Indian Promoters % 74.5 71.5 104.2%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.6 7.0 8.5%  
FIIs % 1.3 12.6 10.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 23.6 8.8 268.2%  
Shareholders   10,259 26,511 38.7%  
Pledged promoter(s) holding % 35.1 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PANACEA BIOTECH With:   DISHMAN PHARMA  ELDER PHARMA  ALEMBIC LTD  DR. DATSONS LABS  CADILA HEALTHCARE  

Compare PANACEA BIOTECH With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades Strong; Consumer Durables Stocks Drag(01:30 pm)

After opening the day in green, share markets in India have continued the momentum and are trading above the dotted line. Except stocks in the consumer durables sector.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

It's the Best Time to Buy IT Stocks(Daily Profit Hunter)

Aug 16, 2017

The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PANACEA BIOTECH SHARE PRICE


Aug 23, 2017 03:36 PM

TRACK PANACEA BIOTECH

  • Track your investment in PANACEA BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PANACEA BIOTECH

PANACEA BIOTECH 8-QTR ANALYSIS

COMPARE PANACEA BIOTECH WITH

MARKET STATS